logo-loader

Flying Brands hails South Korean distribution agreement for Stonechecker kidney stone analysis software

Published: 07:50 06 Mar 2018 GMT

Kidney analysis
By using the StoneChecker software, a significant portion of the estimated US$50mln spent on conducting failed lithotripsies in South Korea each year could be saved

Flying Brands Ld (LON:FBDU) said its subsidiary, StoneChecker Software, has signed an exclusive marketing and distributor arrangement with Korea Computer Motion ISG.

The medical services and software company said the agreement is for sales and distribution of the StoneChecker kidney stone analysis software in South Korea.

READ: Flying Brands heads higher as it gets CE mark for kidney stone medical imaging software

Nick Stevens, the chief executive officer of StoneChecker, said the distribution agreement would support the expansion of StoneChecker in the rapidly growing and important South Korean medical imaging market.

“We are confident that by working with an experienced team led by the CEO Jacob Woo, who has a great understanding of the market and customer base, we stand to increase StoneChecker's revenue potential, market reach and meet our customers' needs," Stevens said.

WATCH: StoneChecker secures first major marketing and distribution contract

Woo said the StoneChecker software addresses a big gap in the urology-radiology market.

“StoneChecker is already attracting a lot of interest amongst the top university hospitals around the world and in South Korea (potential-customers). I anticipate a very successful business relationship and rapidly increasing StoneChecker software sales. Our team has a first-class reputation amongst radiologists and clinicians in the region, and offers unrivalled in-depth market-access and know-how in South Korea," Woo said.

 

 

IQ-AI advances glioblastoma clinical trial, eyes phase two in 2025

Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) sponsored phase one clinical trial that is being conducted at the Medical College of Wisconsin, joined Proactive's Stephen Gunnion with a positive update from its treatment for recurring...

on 23/2/24